1 / 39

Opioid Induced Hyperalgesia

Opioid Induced Hyperalgesia. Jill Mosby, MD June 18 th 2008. History OIH. 1880: Rossbach “When dependence on opioids finally becomes an illness of itself, opposite effects like restlessness , sleep disturbance, hyperesthesia, neuralgia, and irritability become manifest” 2. History OIH.

dana
Download Presentation

Opioid Induced Hyperalgesia

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Opioid Induced Hyperalgesia Jill Mosby, MD June 18th 2008

  2. History OIH • 1880: Rossbach “When dependence on opioids finally becomes an illness of itself, opposite effects like restlessness, sleep disturbance, hyperesthesia, neuralgia, and irritability become manifest” 2

  3. History OIH Six decades later Himmelsbach described opioid abstinence syndrome: “aching in bones, joints, muscles is probably the most common withdrawal symptom” 2

  4. Definitions Analgesia • absence of sense of pain Nociceptive • Causing pain Agonist • a chemical substance capable of activating a receptor to induce a full or partial pharmacological response Antagonist • a drug that counteracts the effects of another drug

  5. More definitions TOLERANCE • Exposure to a drug induces changes that cause decreased response to drug’s effects over time • Can develop quickly or slowly • Cross tolerance can occur (ie: with opioids) SENSITIZATION • A form of nonassociative learning characterized by an increase in responsiveness upon repeated exposure to a stimulus

  6. Standard Risks of Opioid • Physical dependence • Tolerance • Addiction • Overdose • Typical side effects • ? Opioid Induced Hyperalgesia

  7. Opioid Induced Hyperalgesia • Enhanced pain response to a noxious stimulus • Evidence for changes/ source in spinal cord and brain • AKA: Opioid Neurotoxicity

  8. Types of OIH • Maintenance therapy and withdrawal (MW) • Very high dose, or escalating dose (HD) • Ultra-low dose (LD)

  9. Early evidence OIH: MW Rodent Studies Summery • Rodents: mice, rats, guinea pigs • > 75 studies since 1970’s • Multiple opioids (Morphine, Fentanyl, Heroin, experimental) • Multiple routes (IT/SQ/IV/PO/IP) • Time frame of OIH: hours, days, or longer • Pain threshold measured: Mechanical, Electrical or Thermal stimuli This must not be one of the experimental rats…it’s too happy!

  10. Rat studies: during opioid exposure Vanderah et al, J Neurosc 2001 Angst (chart)

  11. Rats: Persistent hyperalgesia Celerier et al, J Neurosc 2001 Angst (chart)

  12. Rats: Persistent hyperalgesia Celerier et al, J Neurosc 2001 Angst (chart)

  13. Celerier et al, J Neurosc 2001

  14. Acute hyperalgesia after isolated exposure Celerier et al, Anes 2000 Angst (charts)

  15. Mechanisms studied OIH-MW • Opioid receptors: Mu receptor ↑ • NMDA antagonist (ketamine, MK-801) ↓ • NMDA activation ↑ • PKC inhibition ↓ • IT glutamate/ substance P ↑ • Spinal EAA (increase in chronic opioid use) ↑ • IT Cyclooxygenase inhibitors (NSAID) ↓ • Spinal dynophin ↑ • Spinal cytokines ↑ • IT GM1 ganglioside ? • Dorsal horn Fos-C ? • Hemoxygenase & nitric oxide synthase inhibitors ↓

  16. Evidence for MW in humans • Human studies former opioid addicts • Maintained on methadone vs. no maintenance • Show increased sensitivity to some types of pain

  17. OIH: MW • Surgery pts, volunteer • High vs. low/no opioid dose intraop • Increased postop pain, opioid use in pts received high dose Angst Anesth 2006

  18. Chronic Pain Patients • 6 Pts chronic back pain >6 months • Started on LA morphine • ↓ Tolerance & Threshold of CPP • Pain scores ↓ 30% • Secondary outcomes not changed Angst J Pain 2006

  19. OIH: MW • Human volunteers • Capsaicin-heat for mechanical pain • Pain ↓ remifentanil • Pain & allodynia ↑ after infusion Wood, Anesth Analg

  20. Clinical significance of MW • Argues acute & chronic opioid use may have new risk: OIH (MW) • Opioids may worsen initial pain & ↑ sensitivity to other sources of pain • Query NMDA antagonists future role help prevent OIH

  21. OIH: LD Animal Studies • Animal studies opioid 1000x lower normal dose: OIH to mechanical & thermal • Locally injected LD→hyperalgesia Normal dose→antinociceptic Both reversed with antagonist • Theory: LD opioid trigger excitatory signaling cascade

  22. OIH: LD in Humans • 1940’s study biphasic response to morphine in 7/57 former addicts. Mild hyperalgesia to heat at low dose, analgesia at high dose. • 1979 study showed LD opioid & antagonist had improved post op pain, but was not confirmed repeat studies • No controlled studies in humans

  23. OIH: HD in Animal studies • IT morphine 10x normal: scratching/ biting/ aversion to touch, not resolved with naloxone • IT strychnine: allodynic/ hyperalgesic • Spinal cord EP studies: HD opioids act similar to IT Strychnine • IT injected Glycine: attenuates allodynia

  24. OIH: HD in Animal Studies • 33 opioid related structures studied, characteristic of chemicals produce allodynia/ hyperalgesia: • Phenantrene structure • Hydrogen at position 14 • Ether bond • One or no methyl group on nitrogen • Free 3-OH position ro glucuronide/sulfate conjugate

  25. OIH: HD in humans • Nine case reports pts with allodynia • 22 pts, 8 had myoclonus • Most patients morphine • Routes: PO, IV, IT • Reducing dose opioid or rotation resolved/ reduced sx in 21/22 pts • This is the OIH that is seen clinically in palliative care, ? Rad-Onc

  26. OIH: HD Clinical Picture • Severe allodynia • Intractable, escalating pain on HD/ED opioid • < 50% myoclonus (?), more at rest • Delirium, mental status changes • Increased doses caused ↑ pain • Can lead to sz, coma, death • Reducing dose or rotating opioid reversed sx in almost all patients

  27. Culprit Medications • *Morphine is most common • most used opioid • *Dilaudid • Oxycodone • Less often fentanyl or methadone • * I have seen clinically this year

  28. Mechanism HD • Phenantrene structure linked • NMDA linked, with effects on excitatory signals in CNS • ? Metabolites of opioid (Morphine-3-glucuronide), this is less discussed in literature

  29. Phenantrene ring

  30. Barriers to Treatment • Clinicians often do not know about, recognize, or understand OIH • Family/ patients understanding: How can my Morphine do harm? • Both groups need education

  31. Management of HD • Pain controlled/ mild: ↓ opioid dose • Uncontrolled pain: ↓ dose + adjuvant OR rotate to non-phenantrene opioid • Benzodiazapines • Fluids • Educate Davis M, Walsh D

  32. Bottom Line • Future of pain control will be greatly influenced by this area of research • Peripheral nerves, spinal cord & CNS all involved in OIH • Chronic pain could be worsened by acute and ongoing opioid therapy

  33. Bottom Line (cont’d) • For Patients with resistant/ escalating pain, hyperalgesia should be considered • OIH (HD) treat with decreased opioid dose or rotation to another opioid • I hope this has given some insight into some of the challenges in treating pain • I hope this helps you recognize OIH (HD)

  34. Questions to ponder • Opioid tolerance & hyperalgesia linked? • Worsening chronic non-malignant pain? • Are there genetic differences that cause OIH MW & HD? • What is on horizon to help HD OIH? Ketamine like medication?

  35. Bibliography • Angst MA, Clark JD: Opioid induced hyperalgesia. Anesth 2006; 104: 570-87 • Mercandante S, Ferrera P, et al: Hyperalgesia: an emerging Iatrogenic Syndrome. J Pain and Sympt Management 2003; 2: 769-775 • Davis MP, Shaiova LA, Angst MS: When opioids cause pain. 2007; 25: 4497-4498 • Chang G, Chen L, Mao J: Opioid tolerance and hyperalgesia. 2007; 91: 199-211

  36. Bibliography • Ballantyne JC, et all: Opioid Induced Hyperalgesia. Pain: Clinical Updates 2008; 16: 1-4 • Celerier E, Rivat C, et al: Long-lasting Hyperalgesia Induced by Fentanyl in Rats. Anesth 2001; 92: 465-72 • Celerier E, Laulin JP, et al: Progressive Enhancement of Delayed Hyperalgesia Induced by Repeated Heroin Administration: a Sensitization Process. J Neurosc 2001; 21: 4074-80 • Chu LF, Clark DJ, et al: Opioid Tolerance and Hyperalgesia in Chronic Pain Patients after one month of oral morphine therapy: a preliminary prospective study. J Pain 2006; 7:43-48 • Hood DD, Curry R, Eisenach JC: Intravenous remifentanyl produces withdrawal hyperalgesia in volunteers with capsaicin-induced hyperalgesia. Anesth Analg 2003; 97: 810-5

More Related